MATINAS BIOPH.HLD.DL-,001 Forum: Community User: Moma

Hast du richtig gemacht,habe auch schon eine Position angelegt.👍

May 31, 2022  Matinas BioPharma to Present at the LD Micro Invitational XII Conference BEDMINSTER, N.J., May 31, 2022 (GLOBE NEWSWIRE) --Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, announced today that Jerry Jabbour, Chief Executive Officer, has been invited to present at the LD Micro Invitational XII Conference on Tuesday, June 7, 2022, at 3:30 p.m. ET (12:30 p.m. PT). The conference is being held at the Four Seasons Hotel in Westlake Village, Calif. Investors interested in arranging a meeting with the Company’s management during the conference should contact the LD Micro conference coordinator. A webcast of the presentation will be available on the IR Calendar page of the Investors section of the Company’s website (www.matinasbiopharma.com) and streamed live by LD Micro. An archived replay will be available on the Company’s website following the event for 90 days. About Matinas BioPharma Matinas BioPharma is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology. The Company is developing its own internal portfolio of products as well as partnering with leading pharmaceutical companies to develop novel formulations that capitalize on the unique characteristics of the LNC platform. Preclinical and clinical data have demonstrated that this novel technology can provide solutions to many of the challenges in achieving safe and effective intracellular delivery, for both small molecules and larger, more complex molecules, such as mRNA, DNA plasmids, antisense oligonucleotides, and vaccines. The combination of a unique mechanism of action and flexibility with formulation and route of administration (including oral), positions Matinas’ LNC technology to potentially become the preferred next-generation intracellular drug delivery vehicle with distinct advantages over both lipid nanoparticles and viral vectors. The Company is focused on developing an internal and external pipeline of drugs candidates based on the LNC platform. Internally, the Company has two clinical stage assets. MAT2203 is an oral, LNC formulation of the highly potent antifungal medicine amphotericin B, currently in Phase 2 clinical trials; MAT2501 is an oral, LNC formulation of the broad-spectrum aminoglycoside, amikacin, primarily used to treat chronic and acute bacterial infections, and currently in Phase 1. Externally, the Company has established a broad set of relationships with multiple global pharmaceutical collaborators, including BioNTech (mRNA), the National Institutes of Health and Gilead Sciences (antivirals), and Genentech, a member of the Roche Group (small molecules, antisense oligonucleotides, and antibody fragments).

Moin an die investierten. Läuft gerade gut.mal schauen wie lange. Morgen Kongress sie oben erster Abschnitt.

Gerade Conference zieht gewaltig an.

Oh danke, habe ich jetzt erst gesehen. Zum Schluss aber wieder ein wenig abgegeben, oder? Performt jedenfalls besser als BNT zur Zeit.

Moin zusammen, denen die schon da sind einen schönen Tag heute 🍀 und kommt gut zur Arbeit

https://www.globenewswire.com/news-release/2022/05/31/2453082/32419/en/Matinas-BioPharma-to-Present-at-the-LD-Micro-Invitational-XII-Conference.html

Um 13 Uhr ist es sprunghaft angestiegen. Ist da was passiert ?

Muss man gluck haben da arbeiten insgesamt 30 leute..was ...was

Wünsche ich dir auch swenni

Offiziel habe in die firma investiert..wunsche allen gluck..trinken wir was

Ja, aber diese Lang und Schwarz Sachen sind nicht wirklich preistreibend.

Ing diba von 8.00 bis 22.00.

ING 8.03 Uhr. Ich hab aber nur sehr weniger als FR in der Order eingegeben.

Sorry, ich muss mich erst an die neuen Funktionen gewöhnen ... Der Handel in USA ist ca. 700 Mal höher als bei uns. Wenn man bei seinem Broker diesen Wert generell handeln kann, funktioniert es ab 15:30 mit dem US Börsenstart. Ich bin bei der Comdirect.